107 related articles for article (PubMed ID: 1997941)
21. Association of tumor cell proliferation with lymph node metastasis in early gastric cancer.
Maeda K; Chung YS; Onoda N; Ogawa M; Kato Y; Nitta A; Arimoto Y; Kondo Y; Arakawa T; Sowa M
Oncology; 1996; 53(1):1-5. PubMed ID: 8570123
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
[TBL] [Abstract][Full Text] [Related]
23. DNA ploidy, Ki-67 and p53 as indicators of lymph node metastasis in early gastric carcinoma.
Sasaki O; Kido K; Nagahama S
Anal Quant Cytol Histol; 1999 Feb; 21(1):85-8. PubMed ID: 10068782
[TBL] [Abstract][Full Text] [Related]
24. Ki-67 labeling index in breast cancer.
Crispino S; Brenna A; Colombo D; Flores B; D'Amico S; Lissoni P; Barni S; Paolorossi F; Bratina G; Tancini G
Tumori; 1989 Dec; 75(6):557-62. PubMed ID: 2694554
[TBL] [Abstract][Full Text] [Related]
25. [Proliferative activity in gastric cancer with Ki-67 and propidium iodide: analysis by flow cytometry].
Kimura H; Yonemura Y; Ohyama S; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):388-92. PubMed ID: 1603045
[TBL] [Abstract][Full Text] [Related]
26. Determination of growth fraction index in mammary carcinoma using MIB-1 monoclonal antibody: estimation of whole tumor proliferative potential using biopsy specimens.
Oda K; Yokoi S; Kanda H; Shibuya M; Kamiya S; Horisawa M; Niinomi N; Suzuki M; Hayakawa S; Kishikawa S
Tokai J Exp Clin Med; 1995 Jul; 20(2):81-8. PubMed ID: 8797264
[TBL] [Abstract][Full Text] [Related]
27. Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki-67 in malignant lymphomas.
Kawauchi K; Sato Y; Furuya T; Watanabe S
Hematol Oncol; 1989; 7(4):257-65. PubMed ID: 2472342
[TBL] [Abstract][Full Text] [Related]
28. Ki-67 immunostaining in human breast tumors and its relationship to prognosis.
Wintzer HO; Zipfel I; Schulte-Mönting J; Hellerich U; von Kleist S
Cancer; 1991 Jan; 67(2):421-8. PubMed ID: 1845945
[TBL] [Abstract][Full Text] [Related]
29. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
31. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
Lellé RJ
Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
[TBL] [Abstract][Full Text] [Related]
32. Growth fractions of human renal cell carcinoma defined by monoclonal antibody Ki-67. Predictive values for prognosis.
Yuba H; Okamura K; Ono Y; Ohshima S
Int J Urol; 2001 Nov; 8(11):609-14. PubMed ID: 11903687
[TBL] [Abstract][Full Text] [Related]
33. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
34. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
Kang SM; Kim WH; Kim CW; Kim YI
J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma.
Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
J Am Coll Surg; 1997 Oct; 185(4):398-403. PubMed ID: 9328389
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of cell proliferation in gastric carcinomas with the monoclonal antibody Ki-67. A study of 24 cases.
Hoang C; Polivka M; Maragi JA; Valleur P; Nemeth J; Galian A
Histol Histopathol; 1993 Jan; 8(1):149-53. PubMed ID: 8443426
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of epidermal growth factor receptor status and clinical outcome in gastric carcinoma].
Yonemura Y; Sugiyama K; Kamata T; Fushida S; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Oct; 89(10):1611-5. PubMed ID: 2849039
[TBL] [Abstract][Full Text] [Related]
38. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.
Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T
J Urol; 1991 Apr; 145(4):846-9. PubMed ID: 2005717
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer.
Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K
Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.
Müller W; Schneiders A; Meier S; Hommel G; Gabbert HE
Br J Cancer; 1996 Sep; 74(5):759-65. PubMed ID: 8795579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
